Abstract:Background Increasing evidence indicates that L-dopa decarboxylase (DDC), which mediates aberrant amino acid metabolism, is significantly associated with tumor progression. However, the impacts of DDC are not elucidated clearly in clear cell renal cell carcinoma (ccRCC). This study aimed to evaluate DDC prognostic value and potential mechanisms for ccRCC patients. Methods Transcriptomic and proteomic expressions of and clinical data including 532 patients with ccRCC (The Cancer Genome Atlas RNA-seq data), 226 ccRCC samples (Gene Expression Omnibus), 101 ccRCC patients from the E-MTAB-1980 cohort, and 232 patients with ccRCC with proteogenomic data (Fudan University Shanghai Cancer Center) were downloaded and analyzed to investigate the prognostic implications of DDC expression. Cox regression analyses were implemented to explore the effect of DDC expression on the prognosis of pan-cancer. The "limma" package identified the differentially expressed genes (DEGs) between high DDC subgroups and low DDC groups. Functional enrichments were performed based DEGs between DDC subgroups. The differences of immune cell infiltrations and immune checkpoint genes between DDC subgroups were analyzed to identify potential influence on immune microenvironment. Results We found significantly decreased DDC expression in ccRCC tissues compared with normal tissues from multiple independent cohorts based on multi-omics data. We also found that DDC expression was correlated with tumor grades and stages.The following findings revealed that lower DDC expression levels significantly correlated with shorter overall survival (P <0.001) of patients with ccRCC. Moreover, we found that DDC expression significantly correlated with an immunosuppressive tumor microenvironment, higher intra-tumoral heterogeneity, elevated expression of immune checkpoint CD274, and possibly mediated malignant behaviors of ccRCC cells via the PI3k/Akt signaling pathway. Conclusion The present study is the first to our knowledge to indicate that decreased DDC expression is significantly associated with poor survival and an immune-suppressive tumor microenvironment in ccRCC. These findings suggest that DDC could serve as a biomarker for guiding molecular diagnosis and facilitating the development of novel individual therapeutic strategies for patients with advanced ccRCC.

DCN deficiency promotes renal cell carcinoma growth and metastasis through downregulation of P21 and E-cadherin

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling

Effect of Decorin Gene Overexpression on Migration and Invasion of Cholangiocarcinoma Cells

Methylated+58cpg Site Decreases Dcn Mrna Expression And Enhances Tgf-Beta/Smad Signaling In Nsclc Cells With High Metastatic Potential

Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance

Differential Expression of Decorin in Metastasising Colorectal Carcinoma Is Regulated by miR-200c and Long Non-Coding RNAs

Multi-omics Profiles Refine L-dopa Decarboxylase (DDC) As a Reliable Biomarker for Prognosis and Immune Microenvironment of Clear Cell Renal Cell Carcinoma

Decorin is Responsible for Progression of Non-Small-cell Lung Cancer by Promoting Cell Proliferation and Metastasis

High TXNDC5 Expression Predicts Poor Prognosis in Renal Cell Carcinoma

NDNF Inhibits the Migration and Invasion of Human Renal Cancer Cells Through Epithelial-Mesenchymal Transition

Overexpression of Long Non-Coding RNA Differentiation Antagonizing Non-Protein Coding RNA Inhibits the Proliferation, Migration and Invasion and Promotes Apoptosis of Renal Cell Carcinoma.

Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.

Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis

Overexpression of Decorin Induces Apoptosis and Cell Growth Arrest in Cultured Rat Mesangial Cells in Vitro

Aberrant Methylation and Loss of CADM2 Tumor Suppressor Expression is Associated with Human Renal Cell Carcinoma Tumor Progression

Coiled-coil domain containing 25 (CCDC25) regulates cell proliferation, migration, and invasion in clear cell renal cell carcinoma by targeting the ILK-NF-κB signaling pathway

DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.

Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma

Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.